- Home
- SLGL vs MMD Comparison
SLGL vs MMD Comparison
Compare SLGL & MMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SLGL | MMD |
|---|---|---|
| Founded | 1997 | 2012 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 247.1M | 282.8M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | SLGL | MMD |
|---|---|---|
| Price | $73.50 | $15.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $110.00 | N/A |
| AVG Volume (30 Days) | 28.4K | ★ 43.6K |
| Earning Date | 05-22-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.88% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $223.84 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.96 | $14.39 |
| 52 Week High | $97.97 | $15.82 |
Technical Indicators
Market Signals| Indicator | SLGL | MMD |
|---|---|---|
| Relative Strength Index (RSI) | 51.77 | 59.43 |
| Support Level | $66.85 | $14.94 |
| Resistance Level | $75.00 | $15.81 |
| Average True Range (ATR) | 5.47 | 0.19 |
| MACD | -0.11 | 0.01 |
| Stochastic Oscillator | 42.45 | 81.13 |
Price Performance
Historical ComparisonAbout SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
About MMD MainStay MacKay DefinedTerm Municipal Opportunities Fund
NYLI MacKay DefinedTerm Muni Opportunities Fund is a USA-based diversified closed-end management investment company. The fund's investment objective is to seek current income exempt from regular U.S. Federal income taxes as well as total return. The company predominantly invests in municipal bonds, the interest on which is, in the opinion of bond counsel to the issuers, generally excludable from gross income for regular U.S. Federal income tax purposes.